Man Group PLC Beyond Air, Inc. Transaction History

Man Group PLC

  • $36 Billion
  • Q3 2024

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
BUY
$2.31 - $4.18 $30,198 - $54,645
13,073 Added 29.12%
57,973 $133,000
Q2 2023

Aug 14, 2023
SELL
$4.26 - $6.92 $174,574 - $283,581
-40,980 Reduced 47.72%
44,900 $191,000
Q1 2023

May 15, 2023
BUY
$5.65 - $7.56 $368,899 - $493,607
65,292 Added 317.14%
85,880 $579,000
Q4 2022

Feb 14, 2023
BUY
$5.47 - $7.9 $112,616 - $162,645
20,588 New
20,588 $133,000
Q2 2022

Aug 15, 2022
SELL
$4.96 - $7.83 $116,143 - $183,347
-23,416 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$6.33 - $9.53 $148,223 - $223,154
23,416 New
23,416 $156,000

Others Institutions Holding XAIR

# of Institutions
50
Shares Held
15M
Call Options Held
31.6K
Put Options Held
3.4K
View Full List

About Beyond Air, Inc.

XAIR Quotes by TradingView
  • Ticker XAIR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 29,888,000
  • Market Cap $14.6M
  • Description
  • Beyond Air, Inc. operates as a commercial medical device and biopharmaceutical company. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn. The company is also developing LungFit PRO for the treatment ...
More about XAIR
Track This Portfolio

Track Man Group PLC Portfolio

Follow Man Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email